Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
At ASCO 2026, a ‘paradigm shift’ for a rare gut cancer looms
GSK shared early data suggesting its KIT inhibitor from IDRx could overtake Gleevec as the standard of care for gastrointestinal stromal tumors.
Darren Incorvaia
Jun 1, 2026 3:55pm
ASCO: Why Celcuity dares to dream of becoming $10B company
Jun 2, 2026 8:01am
PATH-Solution
Brought to you by
Alfresa Holdings Corporation
ASCO: Telix tees up pivotal test for Pluvicto challenger
Jun 1, 2026 4:12pm
ASCO: Takeda touts ‘tremendous potential’ of Innovent bispecific
Jun 2, 2026 4:30am
ASCO: BMS' bispecific ADC puts TROP2 drugs on notice
Jun 2, 2026 8:00am
More News
Roche oral SERD's 1st-line miss spurs new adjuvant trial
Jun 2, 2026 12:45pm
Travere scales Everest with $1.1B deal for BTK inhibitor
Jun 2, 2026 10:30am
ASCO: Cardiff posts updated colorectal data before pivotal push
Jun 2, 2026 9:06am
Fulcrum scraps SCD plan as FDA takes hard line on safety risks
Jun 2, 2026 8:46am
See more stories